5:31 PM
 | 
Feb 23, 2009
 |  BC Extra  |  Clinical News

NS2359 misses depression endpoints

NeuroSearch (CSE:NEUR) said NS2359 ( GSK372475) will no longer be developed for depression after the triple monoamine reuptake...

Read the full 84 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >